MedTrace Logo

Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

NCT02933905 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2016-10-18

No results posted yet for this study

Summary

Influence of the vitreomacular interface on the progression of diabetic macular edema after treatment with intravitreal injection of vascular endothelial growth factor inhibitors

Conditions

Interventions

DRUG

Intravitreal Ranibizumab injection

Sponsors & Collaborators

  • Fundació Institut Germans Trias i Pujol

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-01-31
Completion
2016-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02933905 on ClinicalTrials.gov